An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma

Paul G. Murray, Lawrence S. Young

Research output: Contribution to journalArticlepeer-review

Abstract

Although a pathogenic role for the Epstein-Barr virus (EBV) is largely undisputed for tumors that are consistently EBV genome positive (eg, nasopharyngeal carcinoma, endemic Burkitt lymphoma), this is not the case for classical Hodgkin lymphoma (cHL), a tumor with only a variable EBV association. In light of recent developments in immunotherapeutics and small molecules targeting EBV, we believe it is now timely to reevaluate the role of EBV in cHL pathogenesis.

Original languageEnglish
Pages (from-to)591-596
Number of pages6
JournalBlood
Volume134
Issue number7
DOIs
Publication statusPublished - 15 Aug 2019

Fingerprint

Dive into the research topics of 'An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this